Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - paliperidone - prolonged-release tablet - 3 milligram(s) - paliperidone

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - paliperidone - prolonged-release tablet - 6 milligram(s) - paliperidone

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - paliperidone - prolonged-release tablet - 9 milligram(s) - paliperidone

Evropská unie - angličtina - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidone palmitate - schizophrenia - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.1).

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka d.d., novo mesto - paliperidone - prolonged-release tablet - 3 milligram(s) - other antipsychotics; paliperidone

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka d.d., novo mesto - paliperidone - prolonged-release tablet - 6 milligram(s) - other antipsychotics; paliperidone

Irsko - angličtina - HPRA (Health Products Regulatory Authority)

krka d.d., novo mesto - paliperidone - prolonged-release tablet - 9 milligram(s) - other antipsychotics; paliperidone